EQL Pharma AB (publ) announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced sales was SEK 37.290 million compared to SEK 99.505 million a year ago. Operating income was SEK 3.038 million compared to SEK 11.590 million a year ago. Net income was SEK 2.499 million compared to SEK 11.202 million a year ago. Basic earnings per share from continuing operations was SEK 0.09 compared to SEK 0.39 a year ago.